PGEN logo

PGEN
Precigen Inc

8,931
Mkt Cap
$1.44B
Volume
1.57M
52W High
$5.47
52W Low
$1.26
PE Ratio
-2.91
PGEN Fundamentals
Price
$4.16
Prev Close
$4.08
Open
$4.09
50D MA
$3.81
Beta
1.77
Avg. Volume
3.22M
EPS (Annual)
-$1.37
P/B
69.05
Rev/Employee
$60,525.00
$1,308.69
Loading...
Loading...
News
all
press releases
Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13
Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13 Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13 PR...
PR Newswire·6d ago
News Placeholder
More News
News Placeholder
Precigen (PGEN) to Release Earnings on Wednesday
Precigen (NASDAQ:PGEN) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 13. (View Earnings Report at...
MarketBeat·7d ago
News Placeholder
Precigen (NASDAQ:PGEN) Stock Crosses Below 200 Day Moving Average - Here's Why
Precigen (NASDAQ:PGEN) Share Price Passes Below Two Hundred Day Moving Average - Should You Sell...
MarketBeat·8d ago
News Placeholder
MiMedx (MDXG) Reports Q1 Loss, Tops Revenue Estimates
MiMedx (MDXG) delivered earnings and revenue surprises of +28.57% and +3.49%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
Precigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Hold" by Analysts
Precigen, Inc. (NASDAQ:PGEN - Get Free Report) has earned an average recommendation of "Hold" from the seven brokerages that are covering the company, Marketbeat Ratings reports. One equities...
MarketBeat·17d ago
News Placeholder
Precigen (NASDAQ:PGEN) Trading Up 7.5% - Still a Buy?
Precigen (NASDAQ:PGEN) Trading Up 7.5% - What's Next...
MarketBeat·23d ago
News Placeholder
Precigen (NASDAQ:PGEN) Trading Down 5.6% - Here's Why
Precigen (NASDAQ:PGEN) Trading Down 5.6% - Here's Why...
MarketBeat·29d ago
News Placeholder
Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 4,772,781 Shares of Stock
Precigen, Inc. (NASDAQ:PGEN - Get Free Report) Director Randal Kirk sold 4,772,781 shares of the firm's stock in a transaction on Monday, March 30th. The shares were sold at an average price of $3.30, for a total value of $15,750,177.30. Following the transaction, the director owned 302,213 shares...
MarketBeat·1mo ago
News Placeholder
Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Hold" from Brokerages
Shares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have been assigned a consensus recommendation of "Hold" from the seven research firms that are currently covering the stock, MarketBeat...
MarketBeat·1mo ago
News Placeholder
Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat
Precigen (NASDAQ:PGEN) executives used a fireside chat hosted by H.C. Wainwright to outline the company's transition into a commercial-stage organization following the FDA approval of Papzimeos, the first immunotherapy approved for adults with recurrent respiratory papillomatosis (RRP). The discussi...
MarketBeat·1mo ago
<
1
2
...
>

Latest PGEN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.